IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Akcea Therapeutics Inc

CUSIP: 00972L957 | 6 institutional holders

Quarters

Q3 2020Q2 2020Q1 2020Q4 2019Q3 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile